161 related articles for article (PubMed ID: 26573792)
1. Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response.
Bartkowiak K; Kwiatkowski M; Buck F; Gorges TM; Nilse L; Assmann V; Andreas A; Müller V; Wikman H; Riethdorf S; Schlüter H; Pantel K
Cancer Res; 2015 Dec; 75(24):5367-77. PubMed ID: 26573792
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
Bartkowiak K; Effenberger KE; Harder S; Andreas A; Buck F; Peter-Katalinic J; Pantel K; Brandt BH
J Proteome Res; 2010 Jun; 9(6):3158-68. PubMed ID: 20423148
[TBL] [Abstract][Full Text] [Related]
3. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Boudou E; Pouillart P; Thiery JP; de Cremoux P
Int J Cancer; 2005 Mar; 114(2):291-8. PubMed ID: 15543615
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
7. Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.
Notte A; Rebucci M; Fransolet M; Roegiers E; Genin M; Tellier C; Watillon K; Fattaccioli A; Arnould T; Michiels C
Int J Biochem Cell Biol; 2015 May; 62():1-14. PubMed ID: 25724736
[TBL] [Abstract][Full Text] [Related]
8. Review: Biological relevance of disseminated tumor cells in cancer patients.
Riethdorf S; Wikman H; Pantel K
Int J Cancer; 2008 Nov; 123(9):1991-2006. PubMed ID: 18712708
[TBL] [Abstract][Full Text] [Related]
9. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
10. Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression.
Semesiuk NI; Zhylchuk A; Bezdenezhnykh N; Lykhova A; Vorontsova AL; Zhylchuk VE; Kudryavets YI
Exp Oncol; 2013 Dec; 35(4):295-302. PubMed ID: 24382441
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy.
Ferrer A; Roser CT; El-Far MH; Savanur VH; Eljarrah A; Gergues M; Kra JA; Etchegaray JP; Rameshwar P
Cancer Lett; 2020 Sep; 488():9-17. PubMed ID: 32479768
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
13. Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer.
Gruber I; Fehm T; Taran FA; Wallwiener M; Hahn M; Wallwiener D; Krawzyck N; Hoffmann J; Hartkopf AD
Breast Cancer Res Treat; 2014 Apr; 144(2):353-60. PubMed ID: 24554386
[TBL] [Abstract][Full Text] [Related]
14. Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic Acid-induced 2.
Werner S; Brors B; Eick J; Marques E; Pogenberg V; Parret A; Kemming D; Wood AW; Edgren H; Neubauer H; Streichert T; Riethdorf S; Bedi U; Baccelli I; Jücker M; Eils R; Fehm T; Trumpp A; Johnsen SA; Klefström J; Wilmanns M; Müller V; Pantel K; Wikman H
Cancer Discov; 2015 May; 5(5):506-19. PubMed ID: 25716347
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.
Domschke C; Diel IJ; Englert S; Kalteisen S; Mayer L; Rom J; Heil J; Sohn C; Schuetz F
Ann Surg Oncol; 2013 Jun; 20(6):1865-71. PubMed ID: 23263703
[TBL] [Abstract][Full Text] [Related]
16. The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse.
Hartkopf AD; Banys M; Meier-Stiegen F; Hahn M; Röhm C; Hoffmann J; Helms G; Taran FA; Wallwiener M; Walter C; Neubauer H; Wallwiener D; Fehm T
Breast Cancer Res Treat; 2013 Apr; 138(2):509-17. PubMed ID: 23494674
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
18. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
[TBL] [Abstract][Full Text] [Related]
20. Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients.
Solomayer EF; Becker S; Pergola-Becker G; Bachmann R; Krämer B; Vogel U; Neubauer H; Wallwiener D; Huober J; Fehm TN
Breast Cancer Res Treat; 2006 Jul; 98(2):179-84. PubMed ID: 16552629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
